Domestic and regional players hold nearly 60-70% share in the bacillus coagulans market. Investment in the research and development activities and expansion of existing R&D facilities to launch new products remains a key strategy of domestic and regional players.
In contrast, leading players in the bacillus coagulans market are focusing on expanding their manufacturing facilities in Asia. These players are also focusing on entering into a strategic partnership with regional distributors and suppliers. Some of the notable developments in the bacillus coagulans market include,
- Ganeden, a US-based probiotic ingredient manufacturer, was recently acquired by Kerry Group. As a result of the acquisition, Ganeden technologies will be extended into wider application across Kerry’s developed and developing markets.
- Sabinsa Corp. has opened its new office in Toronto, expanding its presence in Canada. The company has around 30 natural products approved by Health Canada. The new office will facilitate Canadian importers to comply with Canadian regulations.
- Mitsubishi Chemical and JD.Com have entered into a partnership to launch the largest “plant factory” in China based on hydroponic technology. The factory is nearly 11,040 square meters. The factory produces red and green lettuce, spinach, cabbage, coriander, and other vegetables. The factory is able to produce more vegetables compared to the conventional system.
- UAS Laboratories has announced the acquisition of Nebraska Cultures Inc. Through the acquisition, UAS has exclusivity over Lactobacillus Acidophilus DDS-1 and ProDURA brand.
- Throne entered into a joint strategic investment with Kirin Holdings Company and Mitsui & Co. Ltd. This strategic investment will help Throne to expand its personalized health products and technology platform and grow their businesses in Asia.
The report provides a competition scenario and updated information on the leading players. Some of the major players in bacillus coagulans are Mitsubishi Chemical Foods Corporation, Ganeden, Nebraska Cultures, UAS Laboratories, Sabinsa Corporation, Syngen Biotech, Sanzyme, Microbax, Mystical Biotech Pvt. Ltd, Thorne, Aumgene Bioscience, and other key players.
Fact.MR’s study offers incisive insights on the bacillus coagulans market. A summary of the report is available upon request.
For full coverage of the competitive landscape, get in touch with our experts.
Increasing Burden of Chronic Digestive Diseases Worldwide
Changing lifestyle and diet is leading to a rise in chronic digestive diseases across the globe. New clinical studies and research have found that bacillus coagulans help to promote digestive health and encourage a healthy immune system. Nearly 20% of people who take antibiotics suffer from antibiotic-associated diarrhoea, and bacillus coagulans have found to be an effective remedy.
Positive effects of bacillus coagulans in serious digestive disorders is resulting in increased consumption of fortified foods and beverages. Several foods and beverages companies are adding bacillus coagulans to their products, targeting a large number of people suffering from digestive disorders.
According to the United European Gastroenterology (UEG), there has been a rise in chronic digestive diseases including functional gastrointestinal disorder, alcohol-related digestive disorders, digestive cancers, and pediatric digestive diseases. Digestive cancers account for around 28% of cancer related deaths in Europe.
Bacillus coagulans have emerged as a trending probiotic that helps to maintain gastrointestinal health. Use of bacillus coagulans is rapidly increasing in weight management as it has scientifically shown to burn fat and boost metabolism.
Cosmetics Industry Rapidly Adopting Bacillus Coagulans
Recent studies have shown positive effects of probiotics such as bacillus coagulans, with a significant reduction in inflammation and acne-causing bacteria. Bacillus coagulans is witnessing growing demand in the cosmetic industry, owing to the immense benefits offered in managing skin problems and acne.
New formulations including Bacillus coagulans is being launched by cosmetics providers for anti-aging effects. These products include creams, lotions, face masks, scrubs, cleansers, and gels. Cosmetics product manufacturers are also focusing on developing cosmeceutical ingredients including bacillus coagulans to be used in various cosmetic products including powders, gels, face scrub, lotions, and creams.
Bacillus coagulans are also gaining popularity in managing and treating symptoms of eczema and atopic dermatitis. Its incorporation in cosmetic products including moisturizing cream and anti-acne face wash is also on a rise. Owing to is biological activity and protection of skin, bacillus coagulans is widely used in personal care products.
Promising Application in Non-Dairy Food Products
Health and wellness continues to be at the forefront of new product development strategies with new dairy-free probiotic foods hitting the market each year. There has been an increased demand for non-dairy probiotics owing to the rise in vegan and vegetarian population, desire for low milk cholesterol, a rise in milk protein allergies, and increased lactose intolerance.
Bacillus coagulans is emerging as the main ingredient in the majority of the dairy-free food products. Reported safe by the FDA and EFSA, bacillus coagulans is largely being added in functional food products and dairy-free probiotic supplements.
High stability of bacillus coagulans through processing and heating is leading to growing demand in heat-treated food products. Most of the products used in food industry that can be produced by Bacillus coagulans is gaining popularity due to the low cost and alternative to other harmful chemical sources.
Limited Research and Potential Risk to Challenge Bacillus Coagulans Market Growth
Side-effects of Bacillus coagulans is very mild but carelessness in dosage can result in intestinal gas and bloating. There is an ongoing debate on potential risk and side-effects of bacillus coagulans because it is not naturally present in the digestive system. Various strains of bacillus coagulans have been identified that may not be safe to use as probiotics.
While bacillus coagulans may offer several benefits as compared to other probiotics, the research done on this probiotics is still limited. There is also a concern that spores produced by bacillus coagulans can move out of digestive tract and reach other parts. Hence, it is not recommended for people with immunocompromised conditions, or the person using a catheter as it may lead to bacterial infection.
In a clinical study published in Archives of Internal Medicine, bacillus coagulans infection was identified among patients with leukaemia, lymphoma, and breast cancer. Moreover, bacillus coagulans also interacts with certain drugs that may increase the risk of side-effects and affect immune function.
For a detailed analysis on all the key market factors, request a sample.
Bacillus coagulans is a type of good bacteria used in a similar way as other probiotics. Bacillus coagulans helps to aid digestive disorders and general digestion problems. It also helps in preventing respiratory infections and boost immune system. Bacillus coagulans produces lactic acid, however, unlike lactic acid bacteria, bacillus coagulans form a reproductive structure known as spores. These spores are essential factor in bacillus coagulans and differentiate it from other lactic acid bacteria.
About the Report
The report illustrates key insights and identifies important factors impacting bacillus coagulans market. The report also offers an in-depth analysis of the market along with the qualitative and quantitative analysis. Market dynamics including opportunities, drivers, trends, and challenges in the bacillus coagulans market are also provided in the report.
The study also includes region-wise and segment-wise analysis of the bacillus coagulans market. Competitive landscape and detailed profiles of the leading players in bacillus coagulans is also offered in the report.
The report includes a segment-wise analysis of bacillus coagulans market. The bacillus coagulans market is divided into product type, application, and form. These segments are further divided into sub-segments.
Based on the product type, the bacillus coagulans market is segmented into animal based and plant based. On the basis of form, the market segment includes pellets and capsules.
In terms of the application, the bacillus coagulans market is segmented into food & beverages, cosmetics & personal care, animal feed, pharmaceuticals, and nutraceutical.
Additional Questions Answered
The report offers in-depth analysis of the bacillus coagulans market. The report provides answers to some important questions on the market.
- What will be the revenue share of plant based product in the bacillus coagulans market?
- What will be the volume share of bacillus coagulans in capsule form?
- Which region is expected to remain lucrative in the bacillus coagulans market?
- What are the factors hampering growth of the bacillus coagulans market?
- Which industry is likely to account for the highest consumption of bacillus coagulans?
The report offers valuable insights on the bacillus coagulans market using exclusive methodology. The report provides details on the trends, market drivers, and growth opportunities in the bacillus coagulans market. The primary and secondary research is also done to offer exclusive information on the market. Data and information on the market was collected using valid data sources and by conducting interviews with industry experts.
The report also highlights the latest challenges and changes in the bacillus coagulans market. The report provides details on the latest developments in the market to help players plan future business strategies.
The latest report on the bacillus coagulans market by Fact.MR provides key insights, on the market along with the factors contributing to the market growth. The report also offers historical data and forecast on the bacillus coagulans market. The study covers major factors impacting the growth of the market. Micro and macro-economic factors in the bacillus coagulans market are also highlighted in the report.
Market dynamics which includes key trends, growth opportunities, driving factors, and challenges in the bacillus coagulans market are also focused in the study. The report offers region-wise and segment-wise analysis including all the key countries Competitive analysis of the bacillus coagulans market is also offered in the report.
Chapter 1- Executive Summary
This chapter in the report provide key findings on the market along with the market introduction and megatrends. The report also offers product specific definition of bacillus coagulans. Opportunity assessment on the market is also covered in this chapter.
Chapter 2- Bacillus Coagulans Market Associated Industry
This chapter includes consumer behavior and attitude measurement on other associated industries. It focuses on deciphering consumer buying pattern, decrypting channel preferences, and metamorphosis in consumer behavior. The report tracks market tendencies, product launch, latest buzz and trends in various industries.
Risks and opportunities are also covered in this chapter. Associated risks offered in the report includes regulatory risks, alternatives risks, and certification risks. Opportunities section focuses on niche in existing product line, latent opportunities in market, new product categories, and white spaces in new markets.
Chapter 3- Market Dynamics
This chapter of the report offers in-depth analysis on the key factors that are influencing growth in the bacillus coagulans market. Trends, growth drivers, and opportunities in the key regions are covered in the report. Impact analysis and prominent challenges in the market are also included in this chapter.
Chapter 4- Key Indicator Assessment
This section in the report offers overview of the probiotics market, including global probiotics production. The report provides overview on gummy market along with the key insights on bacillus coagulans market including to producing countries and total production globally. It focuses on key regulatory framework and packaging type for bacillus coagulans. Supply and value chain analysis and macro-economic factors in the bacillus coagulans is also covered in the report.
Porter’s five force analysis, PESTEL analysis, consumer survey analysis, and consumer trends by technology and price is also offered in the report.
Chapter 5- Price Point Analysis
This chapter in the report highlights price point assessment by region and by product type. Price forecast till 2028 is offered along with the pricing analysis. The report also focuses on all the factors influencing pricing in the bacillus coagulans market.
Chapter 6- Bacillus Coagulans Market Analysis and Forecast
This chapter of the report provides in-depth analysis of the bacillus coagulans market on basis of various segments including form type, product type, and application. All these segments are divided into sub-segments for better understanding of the market. Market size in terms of volume, value, year-on-year growth, and CAGR is provided for each segment in the report.
Chapter 7- North America Bacillus Coagulans Market Analysis
This chapter in the report provides market forecast and analysis on the bacillus coagulans market in North America. Details on the growth of the market in key countries in North America is also covered in the report. The market size in the North America is offered in form of value and volume.
Chapter 8- Latin America Bacillus Coagulans Market Analysis
This section of the report focuses on the growth opportunities and trends in the bacillus coagulans market in Latin America. Brief introduction along with the market outlook on the key countries in the region is provided in this chapter. It also covers list of key players by countries, market attractiveness analysis, and impact assessment of the market forces in Latin America.
Chapter 9- Bacillus Coagulans Market in Europe
This chapter in the report provides business outlook in Europe along with the food and beverages market outlook. Country-wise analysis is offered on the market in Europe which includes value and volume forecast and analysis on all the key countries. Market trends, impact assessment, and list of important participants based on the country in Europe is offered in this chapter.
Chapter 10- CIS & Russia Bacillus coagulans Market Analysis and Forecast
This chapter in the report provides in-depth analysis of the bacillus coagulans market in CIS & Russia. All the factors influencing the growth of the market in CIS & Russia are covered in this chapter. The report offers segment analysis on the bacillus coagulans market in CIS & Russia including product type, application, and form type. Latest trends, and challenges along with the list of leading participants in the bacillus coagulans market in CIS & Russia is included in the report.
Chapter 11- Japan Bacillus Coagulans Market Analysis and Forecast
This section of the report focuses on the present scenario of the bacillus coagulans market in Japan. The information and data on the market in Japan is offered in terms of value, volume, CAGR, and year-on-year growth. Segment-wise analysis is also provided on the bacillus coagulans market in Japan.
Chapter 12- Bacillus Coagulans Market in APEJ
This chapter in the report covers all the latest developments and challenges in the bacillus coagulants market in the Asia Pacific Excluding Japan (APEJ) region. The market outlook including volume and value forecast and country-wise demand assessment including all the key countries in APEJ is included in this report. List of the key participants, market attractiveness analysis, impact assessment of market forces, and key trends in the bacillus coagulans market in APEJ is also offered in this chapter.
Chapter 13- MEA Bacillus Coagulans Market Analysis and Forecast
This chapter of the report focuses on all the latest trends and drivers shaping the bacillus coagulans market in the Middle East and Africa (MEA). The chapter highlights all the factors responsible for the growth of the bacillus coagulans market in various countries in the MEA region. The report also provides year-on-year growth, along with the value and volume forecast in the bacillus coagulans market in MEA.
Chapter 14- Competitive Assessment
This chapter in the report provides competitive analysis of the leading players in the bacillus coagulans market across regions. The report offers a dashboard view of the key players, company share analysis, key companies by region, and market structure.
Chapter 15- Bacillus Coagulans Market- Vendor Analysis
This section of the report provides profiles of some of the leading players in the bacillus coagulans market with the specific focus on product and business strategy. Details on the new product launches, latest developments, and focus areas of the key players in the bacillus coagulans market is also covered in the report.
Fact.MR offers custom research services that help clients to get specific research solutions
We are committed towards customer satisfaction and quality service.